Trilegal advises Iswarya Health on securing ₹355 crore investment from OrbiMed

Iswarya Health Private Limited has secured a primary investment of ₹355 crore from OrbiMed Asia VI Mauritius Limited, an investment vehicle of OrbiMed.

Trilegal advised Iswarya Health, and its promoters, Dr. Arun Muthuvel, Dr. S. Chandralekha and Dr. K. Veluswamy, on this transaction.

The transaction was led by Rahul Chugh (Partner), with support from Kriti Chatrath (Senior Associate) and Samridhi Poddar (Associate).

Based in Chennai, Iswarya Health is a healthcare company operating as a provider of fertility services; and has expanded to include a multispecialty hospital with over 400 beds and state-of-the-art infrastructure.

The investment will enable Iswarya Health to establish new centres in existing and underserved markets, strengthen its clinical infrastructure, invest in digital capabilities and expand its embryology talent pipeline. The funding is aimed at supporting Iswarya Health's next phase of growth and expanding access to high-quality fertility care across India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.